Sort
15,842 grants matching “pancreatic cancer”
Combined Modality Targeted Therapy of Pancreatic Cancer with Death Receptor
$178,339Donald J Buchsbaum · University Of Alabama At Birmingham · P50 · FY2011 · CA
Project 2: Intratumoral PDT Induces PDP-based Enhancement of PD-1 Inhibition in Pancreatic Carcinoma
$178,337Kenneth K Wang · Massachusetts General Hospital · P01 · FY2024 · CA
Endocannabinoid Signaling and Obesity-linked Cancer
$178,268Michel Bernier · National Institute On Aging · ZIA · FY2009 · AG
Collagen fibers and fragments regulate pancreatic cancer metabolism and growth.
$178,265Michael Karin · University Of California, San Diego · R01 · FY2025 · CA
Markers for Risk in Familial Pancreatic Cancer
$178,262Ralph H Hruban · Johns Hopkins University · P50 · FY2009 · CA
New transgenic animal model to study pancreatic cancer
$178,234Paul B Fisher · Virginia Commonwealth University · R21 · FY2016 · CA
R21 MPI microRNA directed therapy for treating early stage pancreatic cancer
$178,234Fan Zhang · University Of Florida · R21 · FY2023 · CA
Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro
$178,200Lei Zheng · Johns Hopkins University · K23 · FY2013 · CA
Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro
$178,200Lei Zheng · Johns Hopkins University · K23 · FY2014 · CA
Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro
$178,200Lei Zheng · Johns Hopkins University · K23 · FY2011 · CA
Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro
$178,200Lei Zheng · Johns Hopkins University · K23 · FY2012 · CA
Cohort Study of Biochemical and Genetic Risk Factors for Pancreatic Cancer
$178,110Brian Matthew Wolpin · Dana-Farber Cancer Inst · K07 · FY2013 · CA
Cohort Study of Biochemical and Genetic Risk Factors for Pancreatic Cancer
$178,110Brian Matthew Wolpin · Dana-Farber Cancer Inst · K07 · FY2012 · CA
Non-Oncogene Addiction as a Targeted Therapy for Pancreatic Cancer
$178,024Douglas V Faller · Boston University Medical Campus · R21 · FY2013 · CA
Cx43 phosphorylation modulates Kras mediated pancreas cancer progression
$177,961Paul D Lampe · Fred Hutchinson Cancer Research Center · R21 · FY2012 · CA
Molecular Imaging in the Treatment of Kaposi's Sarcoma
$177,940Richard F. Ambinder · Johns Hopkins University · P50 · FY2012 · CA
Somatic Engineering-based Models of Pancreatic Cancer
$177,884Monte Meier Winslow · Stanford University · R21 · FY2016 · CA
Cohort Study of Biochemical and Genetic Risk Factors for Pancreatic Cancer
$177,867Brian Matthew Wolpin · Dana-Farber Cancer Inst · K07 · FY2010 · CA
CTGF in Pancreatic Tumor Growth
$177,814Amato J. Giaccia · Stanford University · R01 · FY2010 · CA
Cohort Study of Biochemical and Genetic Risk Factors for Pancreatic Cancer
$177,777Brian Matthew Wolpin · Dana-Farber Cancer Inst · K07 · FY2011 · CA
Cohort Study of Biochemical and Genetic Risk Factors for Pancreatic Cancer
$177,777Brian Matthew Wolpin · Dana-Farber Cancer Inst · K07 · FY2009 · CA
Core 3: Family and Population Registries Core
$177,775Francis M Giardiello · Johns Hopkins University · P50 · FY2020 · CA
Mechanisms of anti-tumor activity of group A Streptococcus in pancreatic adenocarcinoma
$177,650Brian A Boone · West Virginia University · R21 · FY2022 · CA
Administrative Core
$177,636Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2015 · CA
Systemic Nanocurcumin for Pancreatic Cancer Therapy
$177,588Anirban Maitra · Johns Hopkins University · U54 · FY2014 · CA